It was reported that activation of PKC-α in the peripheral glia, including SGCs, contributes to glial activation and neuroinflammation, further disrupting autonomic regulation in sensory and sympathetic ganglia under T2DM conditions [48,51]. The gene discussed is PRKCA; the disease is type 2 diabetes mellitus.